Bleomycin induces alveolar epithelial cell death through JNK-dependent activation of the mitochondrial death pathway

Vivian Y Lee1, Clara Schroedl, Joslyn K Brunelle

  • 1Div. of Pulmonary & Critical Care, Northwestern University, Chicago, IL 60611, USA.

Insights

Bleomycin exposure causes lung injury by triggering alveolar epithelial cell death. This study reveals that a JNK-dependent mitochondrial pathway, not receptor-mediated pathways, drives this cell death, offering insights into lung fibrosis mechanisms.

Area of Science:

  • Cell Biology
  • Pulmonary Medicine
  • Toxicology

Background:

  • Bleomycin (BLM) is a chemotherapeutic agent known to induce lung injury and fibrosis in animal models.
  • Alveolar epithelial cell death is a proposed initiating event in BLM-induced lung pathology.
  • Understanding the specific cell death pathways involved is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the roles of mitochondrial and receptor-mediated death pathways in BLM-induced alveolar epithelial cell death.
  • To identify the key molecular regulators, such as stress kinases, involved in this process.

Main Methods:

  • Utilized mouse alveolar epithelial cells (MLE-12) and primary rat alveolar type II cells.
  • Examined the effects of BLM exposure on cell viability.
  • Manipulated expression of key proteins like Bcl-X(L), Fas-associating protein with a death domain, Bax, Bak, and c-Jun N-terminal kinase (JNK).
  • Employed dominant-negative constructs and inhibitors to probe specific signaling pathways.

Main Results:

  • Bleomycin induced cell death in both MLE-12 and primary rat alveolar type II cells.
  • Overexpression of Bcl-X(L) conferred resistance to BLM-induced cell death.
  • Receptor-mediated pathways (Fas/caspase-8) were not involved.
  • Mitochondrial pathway proteins Bax and Bak were critical, as cells deficient in them were resistant.
  • Inhibition of JNK signaling prevented both Bax activation and cell death, indicating JNK is an upstream regulator.

Conclusions:

  • Bleomycin-induced alveolar epithelial cell death is primarily mediated by a mitochondrial death pathway.
  • This pathway is dependent on the activation of stress kinase JNK and downstream effectors Bax/Bak.
  • Receptor-mediated death pathways do not play a significant role in this model of lung injury.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.